Posted in Medical Device Business by Arundhati Parmar on December 21, 2015
Omar Ishrak, CEO of Medtronic, is steering the largest pure-play medtech company at a time of great tumult and change in the industry. In a wide-ranging interview, Ishrak provides answers about the future of medtech and much more.
Back in August, MD+DI sat down for a 40-minute interview with Omar Ishrak, CEO of Medtronic, at the medtech company’s erstwhile headquarters in Minnesota.
The discussion was far-ranging. We talked about innovation, accountable care, mobile health technologies and everything in between.
In discussing innovation, Ishrak was categorical in defending the internal talent of the company that has brought novel products like Reveal Linq, the implantable cardiac monitor, to market. But he also stressed the importance of understanding that the company would freely acquire innovation by buying startups building promising technologies or solutions.
CLICK HERE to view the video of the interview